PMEF
CRGX

Point72 Middle East FZE’s CARGO Therapeutics CRGX Stock Holding History

Point72 Middle East FZE’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,213
Closed -$584K – 310
2023
Q4 		$584K Buy
+25,213
New +$428K 0.02% 777

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Point72 Middle East FZE's CRGX Position: Q1 2024 in Review

Point72 Middle East FZE sold out of CARGO Therapeutics (CRGX) in Q1 2024, closing a stake of 25,213 shares — an estimated $584K sold.

Point72 Middle East FZE first reported a position in CRGX in Q4 2023 and held it in 1 quarter. The position peaked at $584K in Q4 2023. 65 funds tracked by Wall St. Rank hold CRGX as of Q1 2024.

  • Point72 Middle East FZE reported no remaining CARGO Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 25,213 CARGO Therapeutics shares in Q1 2024, an estimated $584K.
  • Point72 Middle East FZE first reported a position in CARGO Therapeutics in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's CARGO Therapeutics position peaked at $584K in Q4 2023.
  • 65 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.